Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer. | Cancers (Basel) | 2023 | 38001634 | PubTator, text mining | PubMed |
| Identification and immune landscape analysis of fatty acid metabolism genes related subtypes of gastric cancer. | Sci Rep | 2023 | 37993654 | PubTator, text mining | PubMed |
| Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37986325 | PubTator, text mining | PubMed |
| Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 37986299 | PubTator, text mining | PubMed |
| Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer. | Sci Data | 2023 | 37985782 | PubTator, text mining | PubMed |
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Inactivation of the tumor suppressor gene Apc synergizes with H. pylori to induce DNA damage in murine gastric stem and progenitor cells. | Sci Adv | 2023 | 37967175 | PubTator, text mining | PubMed |
| An adaptive stress response that confers cellular resilience to decreased ubiquitination. | Nat Commun | 2023 | 37963875 | PubTator, text mining | PubMed |
| HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | 37961464 | PubTator, text mining | PubMed |
| Role of UBE2C in Brain Cancer Invasion and Dissemination. | Int J Mol Sci | 2023 | 37958776 | PubTator, text mining | PubMed |
| Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer. | Int J Mol Sci | 2023 | 37958642 | PubTator, text mining | PubMed |
| A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection. | Cancers (Basel) | 2023 | 37958393 | PubTator, text mining | PubMed |
| The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia. | Cancers (Basel) | 2023 | 37958340 | PubTator, text mining | PubMed |
| PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. | BMC Cancer | 2023 | 37957639 | PubTator, text mining | PubMed |
| Clinicopathological significance and prognostic implications of Ube2v1 expression in colorectal cancer. | Med Int (Lond) | 2023 | 37954522 | PubTator, text mining | PubMed |
| Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency. | JCI Insight | 2023 | 37906280 | PubTator, text mining | PubMed |
| RRP9 and DDX21 as new biomarkers of colorectal cancer. | Medicine (Baltimore) | 2023 | 37904456 | PubTator, text mining | PubMed |
| Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer. | Medicina (Kaunas) | 2023 | 37893423 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals neurovascular-osteochondral network crosstalk during temporomandibular joint osteoarthritis: Pilot study in a human condylar cartilage. | Heliyon | 2023 | 37867837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=13